EF
RNAM

Empowered Funds’s Avidity Biosciences RNAM Stock Holding History

Empowered Funds’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,196
Closed -$303K – 2190
2025
Q4 		$303K Buy
+4,196
New +$271K 0.01% 855

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Empowered Funds's RNAM Position: Q1 2026 in Review

Empowered Funds sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 4,196 shares — an estimated $303K sold.

Empowered Funds first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $303K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Empowered Funds reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Empowered Funds sold 4,196 Avidity Biosciences shares in Q1 2026, an estimated $303K.
  • Empowered Funds first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Empowered Funds's Avidity Biosciences position peaked at $303K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Empowered Funds's 13F filing for Q1 2026, filed 15 May 2026.